Commercial health plan initiation of a co-pay accumulator adjustment program for specialty medications treating autoimmune diseases was associated with significant reductions in medication adherence and persistence.
Andrew J. Epstein, PhD
Advertisement
Articles by Andrew J. Epstein, PhD
Federal parity led to an increase in spending on substance use disorder treatment.
Advertisement
Latest Updated Articles
- The Effects of Federal Parity on Substance Use Disorder Treatment
January 23rd 2014
Advertisement
Advertisement
Trending on AJMC
1
EHA 2026 Late Breakers Deliver Practice-Shifting Phase 3 Data and Novel CAR T Approaches Across Hematology
2
MRD-Guided CLL Treatment Duration: Personalization or Malpractice?
3
Teclistamab Outperforms Len/Dex in High-Risk Smoldering Myeloma With Higher CR Rate, PFS: Omar Nadeem, MD
4
SENTRY Trial Shows Survival, Spleen Benefits in Myelofibrosis: Claire Harrison, MD
5